Aurobindo Pharma has informed about a Press Release dated September 22, 2016, titled ‘Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the Pepfar market’.
The above information is a part of company’s filings submitted to BSE.